Predictive Modeling Of Concentration-Dependent Viscosity Behavior Of Monoclonal Antibody Solutions
Source: Lonza

Solutions of monoclonal antibodies can show increased viscosity at high concentration, which can be a disadvantage during protein purification, filling, and administration. We present a modeling approach employing artificial neural networks (ANNs) using experimental factors combined with simulation-derived parameters plus viscosity data from 27 highly concentrated (180 mg/mL) mAbs. These ANNs can be used to predict if mAbs exhibit problematic viscosity at distinct concentrations or to model viscosity-concentration-curves.
access the Webinar!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Drug Discovery Online? Subscribe today.
Subscribe to Drug Discovery Online
X
Subscribe to Drug Discovery Online
This website uses cookies to ensure you get the best experience on our website. Learn more